High-throughput plasmid content analysis of Borrelia burgdorferi B31 by using luminex multiplex technology

Applied and Environmental Microbiology

Volumn 77, Issue 4, 2011, Pages 1483-1492

  Norris, Steven J ^a   Howell, Jerrilyn K ^a   Odeh, Evelyn A ^a   Lin, Tao ^a   Gao, Lihui ^a   Edmondson, Diane G ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

96-WELL FORMAT; AGAROSE GEL ELECTROPHORESIS; BIOLOGICAL PROPERTIES; BORRELIA; BORRELIA BURGDORFERI; CAUSATIVE AGENTS; CONTENT ANALYSIS; GENETIC DIFFERENCES; GENETIC STUDIES; HIGH-THROUGHPUT; HIGH-THROUGHPUT METHOD; IN-VITRO; INVASIVE PATHOGENS; LUMINEX; LYME DISEASE; MUTANT CLONES; SIGNATURE-TAGGED MUTAGENESIS; SIMULTANEOUS DETECTION;

ELECTROPHORESIS; GENES; MAMMALS; MULTIPLEXING;

THROUGHPUT;

FLUORESCENT DYE; MICROSPHERE;

ADAPTIVE RADIATION; ASSAY; BACTERIAL DISEASE; BACTERIUM; CHROMOSOME; DETECTION METHOD; DISEASE PREVALENCE; ELECTROKINESIS; GEL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC DIFFERENTIATION; GENOME; INVASIVE SPECIES; MAMMAL; MUTATION; PATHOGENICITY; PLASMID; POLYMERASE CHAIN REACTION;

ARTICLE; BORRELIA BURGDORFERI; CLASSIFICATION; GENETICS; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; METHODOLOGY; PLASMID; POLYMERASE CHAIN REACTION; TRANSPOSON;

BORRELIA BURGDORFERI; DNA TRANSPOSABLE ELEMENTS; FLUORESCENT DYES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; MICROSPHERES; PLASMIDS; POLYMERASE CHAIN REACTION;

NORTH AMERICA;

BACTERIA (MICROORGANISMS); BORRELIA; BORRELIA BURGDORFERI; MAMMALIA;

EID: 79953168802     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01877-10     Document Type: Article

References (55)

1. Barbour, A. G. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:521-525.
2. Barbour, A. G. 1988. Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent. J. Clin. Microbiol. 26:475-478.
3. Barbour, A. G., and D. Fish. 1993. The biological and social phenomenon of Lyme disease. Science 260:1610-1616.
4. Bestor, A., et al. 2010. Use of the Cre-lox recombination system to investigate the lp54 gene requirement in the infectious cycle of Borrelia burgdorferi. Infect. Immun. 78:2397-2407.
5. Burgdorfer, W., et al. 1982. Lyme disease, a tick-borne spirochetosis? Science 216:1317-1319.
6. Canica, M. M., et al. 1993. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand. J. Infect. Dis. 25:441-448.
7. Casjens, S. 1999. Evolution of the linear DNA replicons of the Borrelia spirochetes. Curr. Opin. Microbiol. 2:529-534.
8. Casjens, S., M. Delange, H. L. Ley III, P. Rosa, and W. M. Huang. 1995. Linear chromosomes of Lyme disease agent spirochetes: genetic diversity and conservation of gene order. J. Bacteriol. 177:2769-2780.
9. Casjens, S., et al. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35:490-516.
10. Casjens, S., R. van Vugt, K. Tilly, P. A. Rosa, and B. Stevenson. 1997. Homology throughout the multiple 32-kilobase circular plasmids present in Lyme disease spirochetes. J. Bacteriol. 179:217-227.
11. Casjens, S. R., C. H. Eggers, and I. Schwartz. 2010. Borrelia genomics: chromosome, plasmids, bacteriophages and genetic variation, p. 27-53. In D. S. Samuels and J. D. Radolf (ed.), Borrelia: molecular biology, host interaction and pathogenesis. Caister Academic Press, Hethersett, Norwich, United Kingdom.
12. Dever, L. L., J. H. Jorgensen, and A. G. Barbour. 1992. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J. Clin. Microbiol. 30:2692-2697.
13. Eggers, C. H., et al. 2001. Transduction by phiBB-1, a bacteriophage of Borrelia burgdorferi. J. Bacteriol. 183:4771-4778.
14. Elias, A. F., J. Schmutzhard, P. E. Stewart, T. G. Schwan, and P. Rosa. 2002. Population dynamics of a heterogeneous Borrelia burgdorferi B31 strain in an experimental mouse-tick infectious cycle. Wien. Klin. Wochenschr. 114:557-561.
15. Elias, A. F., et al. 2002. Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background. Infect. Immun. 70:2139-2150.
16. Fischer, J. R., N. Parveen, L. Magoun, and J. M. Leong. 2003. Decorinbinding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete. Proc. Natl. Acad. Sci. U. S. A. 100:7307-7312.
17. Floris, R., et al. 2007. Evaluation of a genotyping method based on the ospA gene to detect Borrelia burgdorferi sensu lato in multiple samples of Lyme borreliosis patients. New Microbiol. 30:399-410.
18. Fraser, C. M., et al. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586.
19. Glöckner, G., et al. 2004. Comparative analysis of the Borrelia garinii genome. Nucleic Acids Res. 32:6038-6046.
20. Glöckner, G., et al. 2006. Comparative genome analysis: selection pressure on the Borrelia vls cassettes is essential for infectivity. BMC Genomics 7:211.
21. Grimm, D., et al. 2004. Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle. Infect. Immun. 72:5938-5946.
22. Grimm, D., A. F. Elias, K. Tilly, and P. A. Rosa. 2003. Plasmid stability during in vitro propagation of Borrelia burgdorferi assessed at a clonal level. Infect. Immun. 71:3138-3145.
23. Grimm, D., et al. 2004. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc. Natl. Acad. Sci. U. S. A. 101:3142-3147.
24. Guo, B. P., E. L. Brown, D. W. Dorward, L. C. Rosenberg, and M. Hook. 1998. Decorin-binding adhesins from Borrelia burgdorferi. Mol. Microbiol. 30:711-723.
25. Guo, B. P., S. J. Norris, L. C. Rosenberg, and M. Hook. 1995. Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect. Immun. 63:3467-3472.
26. Hughes, C. A., C. B. Kodner, and R. C. Johnson. 1992. DNA analysis of Borrelia burgdorferi NCH-1, the first north-central U.S. human Lyme disease isolate. J. Clin. Microbiol. 30:698-703.
27. Jewett, M. W., et al. 2007. Genetic basis for retention of a critical virulence plasmid of Borrelia burgdorferi. Mol. Microbiol. 66:975-990.
28. Jewett, M. W., et al. 2007. The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferi. Mol. Microbiol. 64:1358-1374.
29. Kawabata, H., S. J. Norris, and H. Watanabe. 2004. BBE02 disruption mutants of Borrelia burgdorferi B31 have a highly transformable, infectious phenotype. Infect. Immun. 72:7147-7154.
30. Kobryn, K., and G. Chaconas. 2002. ResT, a telomere resolvase encoded by the Lyme disease spirochete. Mol. Cell 9:195-201.
31. Kraiczy, P., et al. 2004. Immunological characterization of the complement regulator factor H-binding CRASP and Erp proteins of Borrelia burgdorferi. Int. J. Med. Microbiol. 293(Suppl. 37):152-157.
32. Labandeira-Rey, M., E. Baker, and J. Skare. 2001. Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect. Immun. 69:446-455.
33. Labandeira-Rey, M., J. Seshu, and J. T. Skare. 2003. The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms. Infect. Immun. 71:4608-4613.
34. Lawrenz, M. B., H. Kawabata, J. E. Purser, and S. J. Norris. 2002. Decreased electroporation efficiency in Borrelia burgdorferi containing linear plasmids lp25 and lp56: impact on transformation of infectious B. burgdorferi. Infect. Immun. 70:4798-4804.
35. Lescot, M., et al. 2008. The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PLoS Genet. 4:e1000185.
36. Liveris, D., et al. 1999. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J. Clin. Microbiol. 37:565-569.
37. Miller, J. C., et al. 2000. A second allele of eppA in Borrelia burgdorferi strain B31 is located on the previously undetected circular plasmid cp9-2. J. Bacteriol. 182:6254-6258.
38. Moody, K. D., S. W. Barthold, and G. A. Terwilliger. 1990. Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 43:87-92.
39. Norris, S. J., C. J. Carter, J. K. Howell, and A. G. Barbour. 1992. Lowpassage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect. Immun. 60:4662-4672.
40. Norris, S. J., J. K. Howell, S. A. Garza, M. S. Ferdows, and A. G. Barbour. 1995. High- and low-infectivity phenotypes of clonal populations of in vitrocultured Borrelia burgdorferi. Infect. Immun. 63:2206-2212.
41. Purser, J. E., and S. J. Norris. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. U. S. A. 97: 13865-13870.
42. Radolf, J. D., J. C. Salazar, and R. J. Dattwyler. 2010. Lyme disease in humans, p. 487-533. In D. S. Samuels and J. D. Radolf (ed.), Borrelia: molecular biology, host interaction and pathogenesis. Caister Academic Press, Hethersett, Norwich, United Kingdom.
43. Sadziene, A., B. Wilske, M. S. Ferdows, and A. G. Barbour. 1993. The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect. Immun. 61:2192-2195.
44. Schutzer, S. E., et al. 8 October 2010. Whole genome sequences of thirteen isolates of Borrelia burgdorferi. J. Bacteriol. doi:10.1128/JB.01158-10.
45. Simpson, W. J., C. F. Garon, and T. G. Schwan. 1990. Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi. Microb. Pathog. 8:109-118.
46. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345:115-125.
47. Stevenson, B., W. R. Zuckert, and D. R. Akins. 2000. Repetition, conservation, and variation: the multiple cp32 plasmids of Borrelia species. J. Mol. Microbiol. Biotechnol. 2:411-422.
48. Stewart, P. E., and P. A. Rosa. 2008. Transposon mutagenesis of the Lyme disease agent Borrelia burgdorferi. Methods Mol. Biol. 431:85-95.
49. Strother, K. O., A. Broadwater, and A. De Silva. 2005. Plasmid requirements for infection of ticks by Borrelia burgdorferi. Vector Borne Zoonotic Dis. 5:237-245.
50. van Dam, A. P., et al. 1993. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin. Infect. Dis. 17:708-717.
51. Xu, Q., et al. 2005. Association of linear plasmid 28-1 with an arthritic phenotype of Borrelia burgdorferi. Infect. Immun. 73:7208-7215.
52. Xu, Y., C. Kodner, L. Coleman, and R. C. Johnson. 1996. Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31. Infect. Immun. 64:3870-3876.
53. Yang, X. F., U. Pal, S. M. Alani, E. Fikrig, and M. V. Norgard. 2004. Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J. Exp. Med. 199:641-648.
54. Zhang, J. R., J. M. Hardham, A. G. Barbour, and S. J. Norris. 1997. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275-285.
55. Zückert, W. R., J. Meyer, and A. G. Barbour. 1999. Comparative analysis and immunological characterization of the Borrelia Bdr protein family. Infect. Immun. 67:3257-3266.